WILMER PALACIOS GONZALEZ: Open Payments
NPI 1245913581 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,070 in 175 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,260 · 2025 $5,070
Food & beverage: $5,050Education: $20
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 56 | $1,353 |
| ABBVIE INC. | 39 | $1,092 |
| Gilead Sciences, Inc. | 9 | $507 |
| Madrigal Pharmaceuticals | 13 | $503 |
| Ardelyx, Inc. | 28 | $459 |
| Janssen Biotech, Inc. | 7 | $390 |
| Phathom Pharmaceuticals, Inc. | 7 | $206 |
| GENZYME CORPORATION | 3 | $175 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| QOL Medical, LLC | 3 | $70 |
Products named: XIFAXAN, RINVOQ, REZDIFFRA, IBSRELA, TREMFYA, DUPIXENT, LINZESS, Livdelzi.
Industry payments across CA — which companies pay providers there.
